GCANPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.14+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.13M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Trafalgar International has not reported a dividend
No dividend per share appears in Trafalgar International's annual filings since fiscal 2015.